Novo Nordisk’s weight-loss drug Wegovy demonstrates heart benefits in latest trial
Novo Nordisk’s groundbreaking obesity drug, Wegovy, has been shown to offer significant cardiovascular advantages, according to the results of a major late-stage trial announced on Tuesday (8th of August, 2023). This revelation not only highlights the efficacy of the medication but also helps in reshaping its perception beyond merely being a lifestyle drug. The clinical study, named...Read More
Hypothalamic differences discovered in people who are living with overweight or obesity
A groundbreaking study by researchers at the University of Cambridge has provided new insights into the role of the hypothalamus in controlling appetite. This small yet critical region of the brain, which is about the size of an almond, appears to have structural differences in those who are living with overweight or obesity compared to those of healthy weight. Dr. Stephanie Brown from the...Read More
Obesity linked to impairment of immune cells protecting against psoriasis
Obesity is more than just a condition associated with excess weight; it can also influence the immune system in ways that make the body more susceptible to certain diseases. Recent research has shed light on how obesity may impair immune cells that protect against inflammation associated with psoriasis, a common skin disorder. This newfound understanding could pave the way for new treatments...Read More
Revolutionising patient care: South Yorkshire’s cutting-edge digital health hub
Set to transform patient care, the South Yorkshire Digital Health Hub is a groundbreaking £4 million project with ambitious goals. It aims to revolutionise the treatment and diagnosis of diseases for a population of 1.4 million people living in a region heavily impacted by high disease prevalence and pronounced health inequalities. This initiative, led by the University of Sheffield,...Read More
Pioneering digital health startups target U.S. maternal health challenges
The escalating maternal health crisis in the U.S., highlighted by a disconcerting 40% surge in maternal deaths during or shortly after pregnancy to 1,205 in 2021, is instigating an urgent response from the digital health sector. Startups like Pomelo Care, Maven Clinic, and Babyscripts are harnessing virtual services to bridge the maternal care gaps and mitigate pregnancy-related...Read More
Revolutionary AI tool forecasts pancreatic cancer risk up to three years in advance
Ground-breaking research spearheaded by Harvard Medical School, in collaboration with the University of Copenhagen, VA Boston Healthcare System, Dana-Farber Cancer Institute, and the Harvard T.H. Chan School of Public Health, has developed an artificial intelligence (AI) instrument capable of identifying individuals at the greatest risk of developing pancreatic cancer up to three years before...Read More